Webinar April 7, 2020

FDA Update During the Coronavirus Pandemic

The number of COVID-19 cases in the U.S. continues to rise, affecting employers and employees in every industry, from hospitality to manufacturing to health care. The FDA plays a critical role in combatting the spread of the coronavirus, and there have been many recent developments that affect FDA-regulated entities during the coronavirus pandemic.

This Alston & Bird webinar will review advice we are giving clients related to:

  • FDA inspection suspension and what that means for medical product manufacturers
  • COVID-19 impact on supply chain and recent FDA guidance
  • Emergency use authorizations regarding testing kits, drugs, PPEs, and ventilators
  • New FDA enforcement policies
  • Defense Production Act, hoarding prevention, and other FDA considerations

For more information, click here.

Meet The Speakers
Media Contacts
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.